Alopecia Areata | Concert Pharmaceutical | CP543.3001
Pharmaceutical Company/Sponsor:
Concert Pharmaceutical
Code:
CP543.3001
Title:
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP543 in Adult Patients with Moderate to Severe Alopecia Areata
Type:
Interventional
Phase:
2
Condition/Disease:
Alopecia Areata
Intervention(s)/Treatment(s):
CTP-543 8 mg BID CTP-543 12 mg BID Placebo
Status:
Active, Not Recruiting
Link for Additional Information:
